Venn Life Sciences signs EUR1m contract

23rd Oct 2015 08:17

(ShareCast News) - Venn Life Sciences has signed a €1m contract with a leading French biotech company.The AIM listed clinical research organisation announced the deal on Friday.The two-phase project is centred on acute T-cell leukaemia, and will cover multiple regions including France, the UK and the US.It will run for 33 months and follows on from a previous successful trial with the same company.Chief executive Tony Richardson said the project "illustrates the high standard of execution for Venn's projects and how this can be used to generate repeat customer business".